Effective, safe, affordable

YUSIMRY™ (adalimumab-aqvh) is an FDA-approved biosimilar* to Humira® (adalimumab)

YUSIMRY delivers the same efficacy and safety as Humira

YUSIMRY works by reducing inflammation in parts of the body, like your digestive system, skin, or joints. YUSIMRY is indicated to treat a number of autoimmune conditions across rheumatology, gastroenterology, and dermatology.

*A biosimilar is a medication that has been approved by the FDA for being highly similar to a previously approved biologic medication, or reference product. This means that studies showed no meaningful differences between YUSIMRY and Humira.

How YUSIMRY can help